Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2

著者: Martine Piccart, Gabriel N. Hortobágyi, Mario Campone, Kathleen I. Pritchard, Fabienne Lebrun, Yoshiaki Ito, Shinzaburo Noguchi, Alejandra Perez, Hope S. Rugo, Ines Deleu, Howard A. Burris, Louise Provencher, Patrick Neven, Michael Gnant, Mikhail Shtivelband, Cheng-Han Wu, Jiaxin Fan, Wentao Feng, T Taran, José Baselga - Annals of Oncology 2014 被引用: 568